About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and future commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. The company is focused on advancing its novel kinase-inhibitor pipeline, with an emphasis on establishing proof of concept that it's oral non-covalent BTK inhibitor, vecabrutinib (SNS-062), is effective in the treatment of ibrutinib-resistant chronic lymphocytic leukemia.

The commitment to advancing oncology treatment and patient care is paramount at Sunesis, and it drives every aspect of our business.

• Our work—pursuing the best possible translational and clinical science to ensure that we deliver important new drugs to patients
• Our workplace—creating a stimulating, teamwork-oriented environment for our people involved in this important work
• Our world—supporting the larger oncology community and the philanthropic organizations that help patients and caregivers

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
description icon
Revenue
$10M–$50M
location icon
Phone number
(415) 625-0000
location icon
Headquarter
395 Oyster Point Blvd., Ste. 400, South San Francisco, CA 94080, US
description icon
Founded
1987

Sunesis Pharmaceuticals Alternatives

Frequently Asked Questions about Sunesis Pharmaceuticals

Who are the decision makers in Sunesis Pharmaceuticals, Inc.?

The decision makers in Sunesis Pharmaceuticals, Inc. are Cindy Lopez, Craig Rodenberger, Joanna Deredita, etc. Click to Find Sunesis Pharmaceuticals, Inc. decision makers emails.

Where is Sunesis Pharmaceuticals headquarters located?

Sunesis Pharmaceuticals headquarters is located at 395 Oyster Point Blvd., Ste. 400, South San Francisco, CA 94080, US.

What is Sunesis Pharmaceuticals's annual revenue?

Sunesis Pharmaceuticals generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.

How can I contact Sunesis Pharmaceuticals?

You can contact Sunesis Pharmaceuticals by calling (415) 625-0000.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more